Clinical and research tests for C0677776 - Genetic Testing Registry (GTR) - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

<< First < Prev

Page 5 of 6

Results: 81 to 100 of 104

Tests names and labs	Conditions	Genes, analytes, and microbes	Methods
Comprehensive BRCA1/BRCA2 Testing Defense Health Agency Genetics Reference Laboratory United States Air Force United States	9	2	C Sequence analysis of the entire coding region
Invitae Melanoma Panel Labcorp Genetics (formerly Invitae) LabCorp United States	15	9	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Invitae Prostate Cancer Panel Labcorp Genetics (formerly Invitae) LabCorp United States	15	12	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Invitae Breast Cancer Guidelines-Based Panel Labcorp Genetics (formerly Invitae) LabCorp United States	18	11	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Invitae Multi-Cancer Panel Labcorp Genetics (formerly Invitae) LabCorp United States	138	80	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Invitae Common Hereditary Cancers Panel (Breast, Gyn, GI) Labcorp Genetics (formerly Invitae) LabCorp United States	75	42	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Breast and Ovarian Cancer Panel CeGaT GmbH Germany	7	11	C Sequence analysis of the entire coding region
Hereditary Cancer Panel, Sequencing and Deletion/Duplication ARUP Laboratories, Molecular Genetics and Genomics ARUP Laboratories United States	33	73	D Deletion/duplication analysis E Sequence analysis of select exons C Sequence analysis of the entire coding region
Breast and Ovarian Cancer - extended Diagnostic Panel CeGaT GmbH Germany	7	41	C Sequence analysis of the entire coding region
Hereditary Breast and Gynecological Cancers Panel, Sequencing and Deletion/Duplication ARUP Laboratories, Molecular Genetics and Genomics ARUP Laboratories United States	15	23	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Invitae Breast and Gyn Cancers Guidelines-Based Panel Labcorp Genetics (formerly Invitae) LabCorp United States	26	19	D Deletion/duplication analysis C Sequence analysis of the entire coding region
BRCA2 sequencing Molecular Diagnostics Laboratory Seoul National University Hospital South Korea	1	1	D Deletion/duplication analysis C Sequence analysis of the entire coding region
BRCA1 sequencing Molecular Diagnostics Laboratory Seoul National University Hospital South Korea	2	1	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Colorectal Cancer Panel GeneDx United States	7	20	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Invitae Breast Cancer Panel Labcorp Genetics (formerly Invitae) LabCorp United States	19	14	D Deletion/duplication analysis C Sequence analysis of the entire coding region
BRCA1/2 Sequencing and Del/Dup Analysis GeneDx United States	11	2	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Invitae Breast and Gyn Cancers Panel Labcorp Genetics (formerly Invitae) LabCorp United States	33	23	D Deletion/duplication analysis C Sequence analysis of the entire coding region
BRCA 1 and BRCA2 Gene Sequencing Genomic Research Center Shahid Beheshti University of Medical Sciences Iran	4	2	D Deletion/duplication analysis S Mutation scanning of the entire coding region C Sequence analysis of the entire coding region
Hereditary Breast and Ovarian Cancer Panel Molecular Genetics Laboratory - Diagnostics Genetics LabPLUS - Auckland City Hospital New Zealand	2	8	D Deletion/duplication analysis C Sequence analysis of the entire coding region
BRCA Panel (BRCA1, BRCA2) Quest Diagnostics Nichols Institute San Juan Capistrano United States	1	2	D Deletion/duplication analysis C Sequence analysis of the entire coding region

<< First < Prev

Page 5 of 6

Results: 81 to 100 of 104

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.